Showing results (981-990 of 1,603) with videos related to
Sort By:
Pageof 161
RSC Medicinal Chemistry|March 4, 2026
Harnessing oligonucleotide architecture for potent multivalent inhibition of human carbonic anhydrasesEslam M Abbass, Federico Ladu, Justine Mansot, et al.RSC Medicinal Chemistry|March 5, 2026
Antibacterial peptidomimetics via fragment display on small-molecule scaffoldsEmma Dyhr, Lucía Cañete de Pinedo, Nicki Frederiksen, et al.RSC Medicinal Chemistry|March 18, 2026
Discovery of dihydrospiro[cyclopropane-1,7'-pyrrolo[3,4-d]pyrimidine] derivatives as novel ATR inhibitorsXiaozhen Chen, Yunbo Qian, Yitong Guo, et al.RSC Medicinal Chemistry|March 16, 2026
Peptides as multifunctional linchpins in targeted drug conjugatesXue Li, Yuechen Qian, Jiongjia Cheng, et al.RSC Medicinal Chemistry|February 20, 2026
Novel glycine amides, semicarbazides and fluoroallylamines as inhibitors of the amine oxidase vascular adhesion protein-1 (VAP-1)Timo Pöstges, Jan Kampschulze, Walburga Hanekamp, et al.RSC Medicinal Chemistry|March 4, 2026
Design, synthesis and exploration of cyclic imides as PDE4 inhibitors in psoriasisVeena K S, Pallabi Panja, Tirtha Nath, et al.RSC Medicinal Chemistry|March 4, 2026
Discovery of novel coumarin amphiphiles: dual-action antimicrobials with bacteria-mediated biofilm disruption and host-directed immunomodulationHaiyang Zhang, Qun Tang, Qian Zhu, et al.RSC Medicinal Chemistry|February 16, 2026
Design and optimization of simplified inhibitors targeting Escherichia coli and Klebsiella pneumoniae IspEDanica J Walsh, Rawia Hamid, Tim Giele, et al.RSC Medicinal Chemistry|February 13, 2026
Exploring pyrazoline-thiophene hybrids as CDK2 inhibitors: synthesis, mechanism, biological studies, and computational insightsHeba M Abosalim, Tarek F El-Moselhy, Nabaweya Sharafeldin, et al.RSC Medicinal Chemistry|August 25, 2025
Small molecule drug discovery for Ebola virus diseaseDestiny Durante, Venkatesh Murugesh, Tyler Kalanquin, et al.Pageof 161